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Abstract
Magnetic nanoparticles [MNPs] made from iron oxides have many applications in biomedicine. Full understanding of
the interactions between MNPs and mammalian cells is a critical issue for their applications. In this study, MNPs were
coated with poly(ethylenimine) [MNP-PEI] and poly(ethylene glycol) [MNP-PEI-PEG] to provide a subtle difference in
their surface charge and their cytotoxicity which were analysed by three standard cell viability assays: 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium [MTS], CellTiter-Blue and CellTiter-Glo
(Promega, Southampton, UK) in SH-SY5Y and RAW 264.7 cells The data were validated by traditional trypan blue
exclusion. In comparison to trypan blue manual counting, the MTS and Titer-Blue assays appeared to have consistently
overestimated the viability. The Titer-Glo also experienced a small overestimation. We hypothesise that interactions
were occurring between the assay systems and the nanoparticles, resulting in incorrect cell viability evaluation. To
further understand the cytotoxic effect of the nanoparticles on these cells, reactive oxygen species production, lipid
peroxidation and cell membrane integrity were investigated. After pegylation, the MNP-PEI-PEG possessed a lower
positive surface charge and exhibited much improved biocompatibility compared to MNP-PEI, as demonstrated not
only by a higher cell viability, but also by a markedly reduced oxidative stress and cell membrane damage. These
findings highlight the importance of assay selection and of dissection of different cellular responses in in-vitro
characterisation of nanostructures.
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Background
Magnetic nanoparticles [MNPs] have assumed importance
for the imaging of diseases such as cancer and diabetes
[1]. In the field of tissue engineering, magnetic nanoparti-
cles have been previously reported for many applications
including cellular labelling, sorting and monitoring, tar-
geted in-vivo therapeutic delivery, stem cell replacement
therapy and welding tissue surfaces [2,3]. In 2007, Syková
and Jenelová incorporated superparamagnetic nanoparti-
cles into mesenchymal stem cells for the regeneration of
tissue damage in the central nervous system [4]. They
reported that the superparamagnetic nanoparticles
enabled imaging and control of cellular migration by
external magnetic fields to the wound site, optimised the
number of cells needed and also helped monitor any pos-
sible side effects [4]. Some superparamagnetic nanoparti-
cles were previously approved for imaging and therapeutic
applications in humans, e.g. Feridex IV
® and Combidex
®
(Advanced Magnetics Inc., Lexington, MA, USA) [5-7]
and several other superparamagnetic nanoparticles are
also undergoing phases I and II clinical trials [1,5,8,9].
Despite increased applications of MNPs emerging, little
is known of the adverse biological side effects due to their
nanoscale size. Recently, the importance of such biological
characterisation and cytotoxic profile has been recognised.
The use of appropriate assessments is vital in evaluating
the biocompatibility of MNPs. At present, a range of
assays are used which measure cell viability through non-
specific enzyme activity (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide [MTT], 3-(4,5-dimethylthia-
zol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium [MTS], CellTiter-Blue assay) or via ATP
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any medium, provided the original work is properly cited.level (CellTiter-Glo assay). However, little has been docu-
mented about the possible interactions between nanoparti-
cles and the reagents used in these assays. The validation
of these assays therefore merits urgent investigation.
Recently, Häfeli et al. reported a modification in their
MTT assay used to measure the cytotoxicity of polyethy-
lenoxide-coated magnetic nanoparticles [10]. Fisichella
et al. reported that mesoporous silica nanoparticles inter-
fered with the intracellular trafficking of the MTT forma-
zan vesicles in HeLa cells and astrocytes, resulting in an
overestimation of cytotoxicity when compared to flow
cytometry [11]. In contrast, vast literature has been pub-
lished on the effect of carbon nanotubes [CNTs] on such
assays [12-18]. It has been documented that single-walled
carbon nanotubes interfere with both absorbance and
fluorescent cytotoxicity assays [12-14]. Belyanskaya et al.
reported that the extent of interference can be attributed
to three factors: (1) protocol of the assay, (2) surfactant
coating and (3) chemical architecture of the CNT [12].
Belyanskaya reported that addition of one further centrifu-
gation step at the end of the MTT assay in order to lyse
the cells and discard the cellular components and CNT
particles could reduce interferences caused by the CNTs.
T h e yc o n c l u d e dt h a te x t r e m ec a u t i o ns h o u l db eu s e d
when interpreting cell viability data without appropriate
controls in place [12].
H e r e ,w ed e t e r m i n et h es u i t a b i l i t yo fv a r i o u ss t a n d a r d
cell viability assays for a MNP with a particle size of
100 nm. As MNP surface properties especially surface
charge is an important factor in determining their biocom-
patibility [19,20], the surface of commercial MNPs was
modified with poly(ethylenimine) [MNP-PEI] and further
conjugated with poly(ethylene glycol) [MNP-PEI-PEG].
PEI polymers have been reported to increase solution
properties of nanoparticles and provide a platform for
further modification, such as targeting or solubilisation
moieties [21-23]. PEG has been widely accepted for nanos-
tructure modification and drug delivery due to its biocom-
patibility and stealth properties in vivo [24-27]. Through
surface modification, we obtained two types of MNPs with
controlled difference on their surface charges, MNP-PEI
having a higher positive charge than MNP-PEI-PEG, and
used them as models to analyse the ability of various
assays in discriminating the subtle difference in the level
of effect those nanoparticles could impose to cells.
Another consideration in assessing the sensitivity of the
cell viability assays is MNP concentration. Concentrations
of MNPs closer to physiological conditions and much
lower than that reported in most studies were used in the
present study. We validated the cell viability data obtained
from commonly used MTS, CellTiter-Blue and CellTiter-
Glo assays by comparing them with that obtained with tra-
ditional trypan blue exclusion to evaluate the suitability of
those commercial cell viability assays for nanotoxicity
studies. The validated data were further complemented by
measurement of a number of cellular events in response
to MNPs including cell membrane integrity, reactive oxy-
gen species [ROS] production and lipid peroxidation
[LPO] to give a more comprehensive safety profile.
Methods
Coating and characterisation of magnetic nanoparticles
MNPs (Chemicell GmbH, Berlin, Germany) diluted with
9.5 mL deionised water [DI] were sonicated for 18 h.
N-(3-dimethylaminopropyl)-N-ethylcarboimide hydro-
chloride (5.7 mg) and N-hydroxysuccinimide (11.4 mg)
dissolved in 1.9 mL of 2-(N-Morpholino)ethanesulfonic
acid hemisodium salt [MES] buffer (0.5 M) were added to
the solution and stirred for 1 h at room temperature [RT].
MES buffer (0.1 M) was added, and the solution was cen-
trifuged at 40,000 × g at 4°C for 0.5 h. MNPs were resus-
pended in the MES buffer (0.1 M, 19 mL) containing
0.95 mg PEI (molecular weight [MW] 750,000) and stirred
at RT for 3 h. Glycine (25 mM) in phosphate-buffered sal-
ine [PBS] (9.5 mL) was added, and the solution was stirred
for a further 1 h at RT. The nanoparticles were ‘washed’
with DI (three times), and the resultant MNP-PEI eluted
from the solution using a high-powered magnet. The
nanoparticle pellet was resuspended in 10 mL of DI.
MNP-PEI (4 mL) was added to 0.08 M sodium tetrabo-
rate (12 mL) followed by methoxypolyethylene glycol
p-nitrophenyl carbonate (MW 5,000) (20 mg) with stirring
for 3 h at RT in the absence of light. The resultant solu-
tion was washed with DI, and the MNP-PLL-PEGs eluted
from the solution using a high-powered magnet. The
nanoparticles were resuspended in 4 mL DI.
Nanoparticle concentration was determined using
inductively coupled plasma [ICP] analysis and dispersed in
DI before sonication for 10 min before subsequent mea-
surements. Hydrodynamic diameters, polydispersity index
and zeta potential measurements were carried out using a
photon correlation spectrometer (Zetasizer Nano-ZS, Mal-
vern Instruments, Worcestershire, UK). All measurements
were conducted in triplicate at 25°C, and an average value
was determined. Prior to zeta potential analysis, standard
control samples were run on the instrument.
Culture of cell lines
Two cell lines, SH-SY5Y (human neuroblastoma; ATCC,
Manassas, VA, USA) and RAW 264.7 (mouse macro-
phage), were used in our study. Neuroblastoma cells are
being used to represent cells present at the regenerative
site during nerve regeneration, and macrophage cells are
the body’s first line of defence for the immune system,
phagocytosing foreign bodies and cleaning the blood of
unknown particles; hence, any particles administered to
the site of nerve injury will encounter these cells. SH-
SY5Y cells were cultured in 50:50 Dulbecco’s minimum
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10% heat inactivated foetal bovine serum [FBS], 2 mM L-
glutamine and 1% penicillin streptomycin [Penstrep] (all
purchased from Invitrogen Ltd., Renfrew, UK). RAW264.7
cells (kindly donated by Prof. Colin Watts and Dr Alan
Prescott, College of Life Sciences, University of Dundee,
Dundee, UK) were cultured in DMEM containing 10%
FBS, 2 mM L-glutamine and 1% Penstrep. Cells were
grown under standard conditions (37°C and 5% CO2)t o
reach a confluency of 70% to 80% before being subjected
to any further experimentation.
Cellular uptake of nanoparticles measured by inductively
coupled plasma
Cells seeded in 6-well plates and incubated with MNPs at
final concentrations of 0, 1.56, 6.25 and 25 μgm L
-1 (the
concentration of MNPs used for all experiments indicates
the concentration of Fe
3+)f o r2 4h .T h em e d i u mw a s
removed, and the cells were thoroughly washed with PBS
for three times, trypsinised and resuspended in medium.
The cell number was counted using a haemocytometer,
and cells were placed in eppendorf tubes (1 × 10
6 cells/
tube). The cell suspensions were centrifuged at 800 rpm
for 5 min, and the supernatant was discarded. Concen-
trated hydrochloric acid (100 μL) was added to the cells,
and the tubes were incubated at 90°C for 0.5 h. The sam-
ples were cooled to room temperature and centrifuged at
1,500 rpm for 10 min. The supernatant was diluted with
deionised water and run on an ICP instrument (Optima
7000V DV, PerkinElmer, Wokingham, UK). A calibration
was carried out using iron standard solutions of 0.5 to
5 μgm L
-1 (R = 0.9999). A control sample of deionised
water was also run.
Observation of cellular uptake of nanoparticles by
transmission electron microscopy
MNPs were added to cells cultured in 75-cm
2 flasks (6.25
μgm L
-1) for 24 h. The cells were washed with PBS (three
times). A 10-mL fixative (4% paraformaldehdye, 2.5% glu-
teraldehyde in PIPES buffer, pH 7.2) was added to the
flasks and incubated for 0.5 h at room temperature. The
cells were scraped off the flask and centrifuged into a pel-
let. The pellet was set in resin, and micron-sized slices
were cut. The specimens were viewed using transmission
electron microscopy [TEM] (JEM.1200ex, JEOL Ltd.,
Herts, England, UK), and images were recorded in digital
imaging plates and scanned in a Ditabis Micron scanner
(Ditabis AG, Pforzheim, Germany).
Cell viability determination by MTS, CellTiter-Blue and
CellTiter-Glo assays
MTS and CellTiter-Blue are colorimetric and fluorescent
assays (respectively) used to measure cell viability via
non-specific redox enzyme activity. CellTiter-Glo is a
luminescent assay used to measure cell viability by ATP
level. Cells (100 μL, 1 × 10
5 cells/ml) were seeded into a
96-well flat-bottomed plate (white for Titer-Glo) and
incubated for 24 h at 37°C with 5% CO2. The medium
was replaced with increasing MNP concentrations (1.56
to 25 μgm L
-1) (in triplicates). The cells were incubated
for 24, 72, 120 and 168 h (for 120- and 168-hr incuba-
tions, the medium was replaced at 72 h with fresh med-
ium containing appropriate concentrations of MNPs).
The cells were washed (with PBS, three times) and
replaced with fresh medium (100 μL). MTS (20 μL) or
CellTiter-Blue (20 μL) reagents were added to the wells,
and the plate was incubated for 4 h protected from light.
Absorbance (MTS) was recorded at 490 nm, and fluores-
cence intensity (CellTiter-Blue) was recorded (excitation
560 nm, emission 590 nm). To eliminate possible inter-
ference between MNPs and assay readings, cells treated
with same concentrations of MNPs but without addition
of assay reagents were used as blank wells. Both assays
were measured on a Tecan M200 multimode plate reader
(Tecan Austria GmbH, Grödig, Austria). CellTiter-Glo
reagent was added to the wells (50 μLa n d5 0 - μL media)
and incubated at room temperature for 10 min protected
from light. The luminescence was recorded using the
same multimode plate reader. As per MTS and Titer-
Blue assays, blank wells (with no reagents) were mea-
sured for luminescence and deducted from the values in
experimental wells. Values of viability of treated cells
were expressed as a percentage of that from correspond-
ing control cells. All experiments were repeated at least
three times. All assay kits were purchased from Promega,
Southampton, UK.
Trypan blue exclusion assay
Cells were seeded into a 12-well plate and incubated for
24 h at 37°C with 5% CO2. The cells were treated as pre-
viously described in MTS, Titer-Blue and Titer-Glo. The
cells were washed with PBS three times and trypsinised.
Trypan blue was added to a 100-μL cell suspension in an
e q u a lv o l u m ea n di n c u b a t e da tr o o mt e m p e r a t u r ef o r
5 min. The viable cells were counted using a Countess™
automated cell counter (Invitrogen, Ltd., Renfrew, UK).
Values of viability of treated cells were expressed as a per-
centage of that from corresponding control cells. All
experiments were repeated at least three times.
Reactive oxygen species assay
Cells were seeded into a 96-well plate (10,000/well) and
incubated for 24 h. Cells were incubated with increasing
MNP concentrations (1.56 to 25 μgm L
-1) for 1, 4, 24 and
72 h. The cells were washed three times with PBS and
incubated for 1 h with 100-μM carboxy-H2DCFDA (Invi-
trogen Ltd., Renfrew, UK) in PBS at 37°C protected from
light. The cells were washed three times with PBS and
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0.5 h. The medium was replaced with PBS. The fluores-
cence intensity of the samples was measured at 560 nm
(excitation) and 590 nm (emission) on a Tecan M200
microplate reader (Tecan Austria). The percentage of
dichlorofluorescin [DCF] fluorescence was calculated in
respect to control cells assumed to be 100%.
a
Lipid peroxidation measurement by thiobarbituric acid
reactive substance assay
Cells in an exponential growth phase were seeded into a 6-
well plate and incubated for 24 h. The medium was
replaced with increasing MNP concentrations (1.56 to
25 μgm L
-1). After incubation, the medium was removed,
and the wells were washed three times with PBS. Cells
were trypsinised and resuspended in 0.5 mL PBS contain-
ing 0.05% butylated hydroxytoluene on ice. The cell sus-
pensions were sonicated for 5 s three times at 40 V and
were kept on ice. Malondialdehyde bis(dimethyl acetal)
[MDA] standard solutions (0 to 5 μM) were prepared, and
100 μL of samples or standards was added to the Eppen-
dorf tubes. Sodium dodecyl sulphate (100 μL, 2%) was
added, and the tubes were incubated for 5 min at room
temperature. Thiobarbituric acid (250 μL) was added to
the eppendorf tubes before incubation at 95°C for 1 h. The
samples were cooled on ice for 10 min and centrifuged at
3,000 rpm for 15 min at 4°C. The supernatant was
pipetted into the wells of a 96-well plate, and fluorescent
measurements were taken at 530 nm (excitation) and
550 nm (emission). The results were calculated as nano-
moles of MDA per milligram of cellular protein. Protein
content was determined by the addition of a 100-μL sam-
ple to a 3-mL Bradford reagent. The samples were mixed
well at room temperature for 5 min, and absorbance was
measured at 595 nm. The absorbance values were com-
pared to a calibration curve carried out using bovine
serum albumin, and the protein concentration was deter-
mined.
a
Cell membrane integrity analysis
Cells were seeded into a 96-well plate (15,000/well) and
grown for 24 h. The medium was replaced with increasing
magnetic nanoparticle concentrations (1.56 to 25 μgm L
-1).
The plates were incubated for 1, 4, 24 and 48 h. After incu-
bation 2 μL of lysis buffer was added to the positive control
wells, and the plate was centrifuged at 1,500 rpm for
10 min at 37°C. After centrifugation, 50 μL of the superna-
tant was removed from each well and placed into a new
plate, and 50 μL of a membrane integrity assay reagent was
added to the wells. The plates were incubated for 10 min
at 37°C protected from light. Twenty-five microlitres of
stop reagent was then added to the wells, and the fluores-
cence of the samples was measured at 560 nm (excitation)
and 590 nm (emission) on the microplate reader. The
percentage of cytotoxicity with respect to the positive
control wells was calculated, whereby the lysed cells
were assumed to have 100% lactate dehyrogenase [LDH]
release.
a
Results
Coating and characterization of magnetic nanoparticles
The particles were successfully coated with PEI and
further functionalised with PEG. ICP was used to deduce
the concentration of the MNPs after each reaction (based
on the total iron content). The concentration after the
initial coating with PEI was 1.39 mg mL
-1 (74% yield) and
1m gm L
-1 (72% yield) after pegylation based on ICP ana-
lysis. After coating, the particles were noticeably more
stable in the solution, especially after pegylation. The size
of the MNPs was determined using photon correlation
spectroscopy which measures the hydrodynamic radius of
the particles in the solution [see Table S1 in Additional
file 1]. The particles were measured at 0.25 mg mL
-1 in
deionised water. With polymer coating, the size of the
commercial Chemicell nanoparticles increased from 101
nm to 146 nm (MNP-PEI); the size further increased upon
pegylation to 361 nm.
T h ez e t ap o t e n t i a lo ft h e‘naked’ MNPs was negative
(-38.2 mV), due to the -COOH groups on the surface of
the particles [see Table S1 in Additional file 1]. Addition
of a cationic polymer such as PEI increases the overall zeta
potential, resulting in a positive value. This assumption
c a nb em a d ed u et ot h ep o s i t i v ec h a r g eo nt h ea m i n e
groups of the polymer backbone, binding to the -COOHs
thus rendering them neutral, plus and unbound amine
groups which will still hold their positive charge. The PEI
coating gave a positive value (+17.7 mV) which indicated
that the polymer had been successfully coated with the
polymer, which is in agreement with the size data [see
Table S1 in Additional file 1]. The zeta potential measure-
ment for the pegylated particle was +12.1 mV. This value
indicated that pegylation had occurred as the zeta poten-
tial increased in negativity compared to that of the MNP-
PEI due to the presence of -OH groups on the particle
surface which is due to the PEG coating (MNP-PEI-PEG)
[see Table S1 in Additional file 1].
Cellular uptake of nanoparticles
Table S2 in Additional file 1 shows the intracellular con-
tent of MNPs in SH-SY5Y and RAW 264.7 cells after 24 h
incubation at different concentrations. In the SH-SY5Y
cells, the cellular uptake was increased ninefold from
2.867 pg to 26.763 pg per cell (at 25 μgm L
-1) upon PEI
coating of the nanoparticles. After pegylation, an eightfold
increase in cellular uptake was observed when compared
to the uncoated MNPs at the same concentration. The
increase in cellular uptake, which is dependent on surface
properties of MNPs, further confirms the coating of the
Hoskins et al. Nanoscale Research Letters 2012, 7:77
http://www.nanoscalereslett.com/content/7/1/77
Page 4 of 12particles. Only a small increase in nanoparticle uptake was
observed in RAW 264.7 upon coating (maximum of 1.6-
fold and 1.7-fold increase by PEI and PEG, respectively)
[see Table S2 in Additional file 1], thus indicating that the
cellular uptake in RAW 264.7 cells is less affected by the
surface properties of the nanoparticles compared to that
in SH-SY5Y cells. This is consistent with the phagocytic
nature of the RAW 264.7 cells. Compared to the SH-SY5Y
cells, the RAW 264.7 cells achieved a lower cellular
uptake; we postulate that the smaller cellular volume of
the RAW 264.7 cells was a limiting factor compared with
the much larger volume of SH-SY5Y cells.
The TEM micrographs were consistent with the ICP
data, for the SH-SY5Y cells increased numbers of intra-
cellular nanoparticles were evident upon coating the
particles with PEI and PEG (Figure 1A1, B1, C1). The
RAW 264.7 images (Figure 1A2, B2, C2) were also in
good agreement with the ICP measurement whereby
PEI and PEG coating had less effect on the total cellular
uptake of the nanoparticles.
Cell viability measured by MTS, CellTiter-Blue and
CellTiter-Glo assays
An interesting phenomenon was observed when measur-
ing the cell viability of both the SH-SY5Y (Figure 2A1, B1)
and RAW 264.7 (Figure 2A2, B2) cells after incubation
with the MNPs using MTS, CellTiter-Blue and CellTiter-
Glo assays. At increased concentrations, the MNPs
became attached to either the cell membrane or the bot-
tom of the plate, appearing as a brown colour in the well
(even after five washes with fresh culture media) (data not
shown). The presence of these MNPs resulted in greater
absorption readings in the MTS assay and thus signifi-
cantly showed an overestimation of the cell viability (p <
0.05). This phenomenon could be explained by the adher-
ence of the sticky polymers to the well surface or the posi-
tive amine groups being attracted to the negative charge of
the cell membrane. After pegylation, the interference
appeared to have been reduced; however, the value of cell
v i a b i l i t yt h a ta p p e a r e dw a sstill larger compared to the
visual inspection of viable cells under microscope (data
not shown).
In CellTiter-Blue assay, viable cells reduce resazurin into
fluorescent resorufin. Similar to the MTS assay, the poly-
mer-coated MNPs caused a significant increase in the
fluorescent measurement (p < 0.05 with exception to
1.56 μgm L
-1 MNP-PEI-PEG on SH-SY5Y cells), giving an
overexpression with a similar trend in time dependency
(Figure 2). This indicated that the presence of the nano-
particle in cellular environments increased the fluorescent
intensity exhibited by the resorufin dye.
The results for the CellTiter-Glo assay (Figure 2)
showed a similar trend to the MTS and CellTiter-Blue
assays. Overall, with increased time and concentration,
no significant difference from the actual cell viability
was observed (based on trypan blue exclusion, see below)
(p > 0.05). This was observed for both cell lines.
This unique phenomenon could be due to a number of
factors, either the presence of the MNPs both intracellular
and on the membrane of the cells or the nanoparticles
themselves interfere with the reagents. In our experiments,
wells with nanoparticles (intracellular or on the cell mem-
brane) and without assay reagents were used as blanks and
were deducted from experimental wells. Furthermore,
nanoparticles with assay reagents in the absence of cells
were also analysed, and no significant effect on absor-
bance, fluorescence or luminescent readout was observed
(data not shown). Therefore, we hypothesise that the
increased absorbance and fluorescence (and to a lesser
extent, luminescence) were only evident and elicited by
the combination of cells, nanoparticles and assay reagents.
Validation of magnetic nanoparticle cytotoxicity with
trypan blue exclusion
Based on the above observations, trypan blue exclusion
was used as the gold standard method to validate the cell
viability data obtained by the above assays (Figure 3). This
method involved direct counting of viable cells and hence
eliminated the possibility of interference from occurring.
The results demonstrated a large difference between the
cell viability data from trypan blue counting and all other
three enzyme activity-based assays, especially those mea-
sured by MTS and CellTiter-Blue which involve a group
of cellular redox enzymes (Figure 2). These values corre-
lated well with visual estimations when observed under
microscope. The trypan blue results clearly showed that
the MNP-PEI-PEG possessed a significantly less cytotoxic
effect to the cells compared with the MNP-PEI, highlight-
ing the significance of surface charge of the nanoparticles
in determining their biocompatibility (Figure 3).
Cellular reactive oxygen species production and lipid
peroxidation upon magnetic nanoparticle treatment
T h ea b o v ed a t ai n d i c a t e dt h a tc o m m e r c i a l l ya v a i l a b l e ,
standard cell viability assay kits may not be suitable for
most nanotoxicity studies. To assess other cellular events
that could contribute to the evaluation of nanotoxicity, we
analysed the oxidative stress induced by MNPs. All results
were expressed as a percentage of control cells which were
assumed to be 100%. MNP-PEI induced ROS production
in a dose-dependent manner (Figure 4). The ROS level
was increased to twofold by MNP-PEI (25 μgm L
-1)i n
SH-SY5Y cells after 72 h compared to that in the control
cells. The maximum induction of ROS in RAW 264.7 cells
was, however, lower than that in SH-SY5Y cells (50%
increase on control) (25 μgm L
-1, 24 h), probably reflecting
the relatively higher basal level of intracellular free radicals
in macrophages [28]. Strikingly, pegylated nanoparticles
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Figure 1 TEM images show cellular uptake of magnetic nanoparticles. A1 MNP incubated with SH-SY5Y cells, A2 MNP incubated with RAW
264.7 cells, B1 MNP-PEI incubated with SH-SY5Y cells, B2 MNP-PEI incubated with RAW 264.7 cells, C1 MNP-PEI-PEG incubated with SH-SY5Y cells
and C2 MNP-PEI-PEG incubated with RAW 264.7 cells. Samples were incubated with cells at 6.25 μgm L
-1 for 24 h, and internalisation of
nanoparticles was analysed by TEM as described in the ‘Methods’ section.
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SY5Y and RAW 264.7 cells at lower concentrations. At
25 μgm L
-1, a small increase of ROS by MNPs in SH-
SY5Y cells was observed compared to that in the control
cells at a 4-h exposure point and remained consistent
thereafter.
One of the major damage by the elevated level of ROS
in cells is oxidation of polyunsatured fatty acids in lipid
(lipid peroxidation, [LPO]). The results from the thiobar-
bituric acid reactive substance assay (Figure 5) showed a
similar trend in the level of LPO to that of the ROS in
response to MNP treatment (Figure 4). In general, at
higher concentrations and longer incubation times, both
the SH-SY5Y and RAW 246.7 cells produced increased
levels of LPO when treated with MNP-PEI. After pegyla-
tion, the nanoparticle-induced membrane stress or degra-
dation was again greatly reduced. These results suggested
that the primary amines on the PEI backbone which
attribute to the positive charge on the MNP surface play
an important role in inducing cellular oxidative stress.
The data also indicated that pegylation of nanoparticles
improves their intracellular stability [29], and hence, with
comparable cellular iron content [see Table S2 in
Additional file 1], less free iron is released to the cytosol
in MNP-PEI-PEG-treated cells so that cellular oxidative
stress was reduced [30].
Effect of magnetic nanoparticles on cell membrane
integrity
Elevated levels of ROS and LPO could cause damage to
the biological membrane. The membrane integrity assay
measures the amount of LDH leakage from the cell into
the culture media. Figure 6A1, A2 suggests that after 1 h
incubation with MNP-PEI, 5% to 10% of the cell mem-
brane had already experienced disruption in both SH-
SY5Y and RAW 264.7 cells, when taking into account that
the basal level of LDH in culture media was about 10% of
the control (’total’ LDH released to the media). The LDH
leakage in SH-SY5Y cells increased with the incubation
time of the MNP-PEI to a maximum of 50% after 72 h;
however, no concentration dependency was exhibited at
each time point (Figure 6A1). The cytotoxic effect of
MNP-PEI on the RAW 264.7 cells remained mostly below
10% at 1, 4 and 24 h; however, a large increase in LDH
leakage was observed at 72 h where approximately 70%
cell membrane damage effect was observed (sevenfold
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Figure 2 Cell viability of SH-SY5Y and RAW 264.7 cells. A1 SH-SY5Y cells incubated with MNP-PEI nanoparticles, A2 RAW 264.7 cells
incubated with MNP-PEI nanoparticles, B1 SH-SY5Y cells incubated with MNP-PEI-PEG nanoparticles and B2 RAW 264.7 cells incubated with MNP-
PEI-PEG nanoparticles. The cells were incubated at different concentrations as indicated over a 72-h incubation. Cell viability was determined
using common assays including MTS assay (square), CellTiter-Blue assay (triangle), CellTiter-Glo assay (circle) and trypan blue counting (diamond).
(n = 3 ± SE). Asterisk denotes significantly increased level of cell viability compared with trypan blue measurement (p < 0.05).
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Page 7 of 12increase from the basal level). Again, the membrane dis-
ruption appeared to be independent of nanoparticle con-
centration (Figure 6A2).
When both the SH-SY5H and RAW 264.7 cells were
incubated with the MNP-PEI-PEG nanoparticles (Figure
6B1, B2), a small but constant (and significant p >0 . 0 5 )
membrane disruption was evident. The amount of LDH
leakage did not appear to be concentrated or time-
dependent. The cytotoxic effect was consistently less
than 10%, indicating that the pegylation of the nanopar-
ticles greatly reduced their ability to damage the cell
membrane.
Discussion
In this study, we successfully coated MNPs with PEI and
further modified them with PEG. The zeta potential
measurements for surface charge correlated well with
the polymer-coupled nanoparticles [see Table S1 in
Additional file 1]. Cellular uptake results [see Table S2
in Additional file 1] for both the SH-SY5Y and RAW
264.7 cells further confirmed the polymer attachment as
the particles coated with the PEI and PEI-PEG had
more favourable surface properties and resulted in a
similar increase in cellular uptake compared to the
uncoated nanoparticles.
The cytotoxicity of the polymer-coated nanoparticles
was determined using three commonly used cytotoxicity
assays: MTS, CellTiter-Blue and Cell-Titer-Glo (Figure
2). Our findings suggest that none of these three assays
were suitable for measuring the cytotoxicity of the nano-
particles studied. In contrast to Häfeli’sf i n d i n g s[ 1 0 ] ,
MTS and Titer-Blue assays gave large overestimations of
t h ec e l lv i a b i l i t yi nb o t hS H - S Y 5 Ya n dR A W2 6 4 . 7c e l l s
when compared to trypan blue exclusion. However, the
Titer-Glo assay appeared to give the closest readings to
those obtained with trypan blue exclusion (Figure 2). It
is important to note that a direct comparison is not
appropriate between these assays as they are testing
enzyme activities in different cellular entities; however,
from these results, general observations have been made.
In our experience, this phenomenon is neither unique
to PEI nor to the MNPs as we obtained similar observa-
tions with other polymers (poly(L-lysine), chitosan,
PEG) with homemade nanoparticles (data not shown).
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Figure 3 Cell viability assessed by trypan blue exclusion. Nanoparticles MNP-PEI and MNP-PEI-PEG at 1.56 (white bar), 3.125 (light grey bar),
6.25 (grey bar), 12.5 (dark grey bar) and 25 μgm L
-1 (black bar) were incubated with SH-SY5Y and RAW 264.7 cells over a period of 168 h. A1
MNP-PEI nanoparticles incubated with SH-SY5Y cells, A2 MNP-PEI nanoparticles incubated with RAW 264.7 cells, B1 MNP-PEI-PEG incubated with
SH-SY5Y cells and B2 MNP-PEI-PEG incubated with RAW 264.7 cells. Experiments were performed three times, and data were expressed as mean
± standard errors. Asterisk denotes significant decrease in viability compared with control cells; square denotes significant increase in cell viability
compared to MNP-PEI samples at a similar concentration and incubation time (p < 0.05).
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Page 8 of 12As apparent in our studies, the interference was
reduced, but not eliminated with pegylation of the catio-
nic polymer-coated particle. In an effort to overcome
this interference, we coated wells with 0.2% w/v silica
solution to prevent the polymer-coated nanoparticles
from attaching to the plates [31]. The results showed
that using the 0.2% w/v silica solution did decrease the
adhesive effect of the nanoparticles on the well surface;
however, all three assays still overestimated the cell via-
bility (data not shown). We hypothesised that if the
MNPs were sticking to the cell membrane, then lysing
cells after incubation with MTS reagents followed by
centrifugation (removing cellular debris) could eliminate
the interference in reading from the nanostructure.
With these additional steps, the interference was
reduced, but not eliminated (data not shown). We pro-
pose that for MTS and CellTiter-Blue assays, the false
i n c r e a s ei nv i a b i l i t ym i g h tb ed u en o to n l yf r o mt h e
physical interference by the nanoparticles (not sup-
ported by our data) but also from changes in cellular
activities involved in redox reactions in response to
MNPs. This hypothesis merits further study.
There are many unknown factors that may influence
the determination of the cytotoxicity profile of nanos-
tructures [32]. Recently, the EU NanoSafety Cluster
group has suggested that at least four methods of deter-
mining cytotoxicity should be used in order to obtain a
reliable safety profile for novel nanomaterials. The pre-
sent study has suggested that for our nanoparticles,
using trypan blue exclusion is the only accurate method
for determining cell viability (Figure 3). Other methods
which are not dependent on cellular redox activities
such as [
3H]-thymidine incorporation and flow cytome-
try should be also considered when studying nanotoxi-
city. We have shown a reduction in toxicity after
pegylation of the MNPs, which could be due to a num-
ber of factors including an increase in the coating dia-
meter upon addition of the PEG moiety [33], thus
increasing the stability of the nanoparticles and further
shielding the cells from the iron oxide core. The catio-
nic charge on the PEI is decreased upon pegylation due
to a reduction in the primary amines on the polymer
backbone hence decreasing the cytotoxic effect on the
cells [34]. Finally, the presence of the PEG moiety may
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Figure 4 ROS production in SH-SY5Y and RAW 246.7 cells. The cells were incubated with MNP-PEI and MNP-PEI-PEG at 1.56 (white bar),
3.125 (light grey bar), 6.25 (grey bar), 12.5 (dark grey bar) and 25 μgm L
-1 (black bar) over a period of 72 h. A1 SH-SY5Y cells incubated with
MNP-PEI, A2 RAW 246.7 cells incubated with MNP-PEI, B1 SH-SY5Y cells incubated with MNP-PEI-PEG, B2 RAW 246.7 cells incubated with MNP-
PEI-PEG. Data were expressed as a percentage of control cells. (n = 3 ± SE). Asterisk denotes significant increase in the percentage of DCF
fluorescence compared with control cells (p, 0.05).
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Page 9 of 12provide ‘stealth’ properties as has been widely reported
[35-38].
I no r d e rt oa c h i e v eam o r ei n - d e p t hu n d e r s t a n d i n go f
t h ed e g r e eo fc y t o t o x i c i t yo ft h eM N P s ,w ea l s oi n v e s t i -
gated the effect the polymer-coated nanoparticles had
on the integrity of the cell membrane and oxidative
stress the MNPs elicited in cells. The ROS level
increased significantly (p < 0.05) in both SH-SY5Y and
RAW264.7 cells when exposed to MNP-PEI, overall in a
dose-dependent manner (Figure 4). LPO in cells exhib-
ited a similar pattern but slightly more fluctuating in
SH-SY5Y cells (Figure 5). These increased ROS and
LPO levels were not apparent upon incubation with
MNP-PEI-PEG. The LDH leaking data showed mem-
brane damage which was independent of nanoparticle
concentrations for MNP-PEI. This is contradictory to
the cell viability (Figure 3) of MNPs which was clearly
dose- and time-dependent. The trypan blue and LDH
assays work on the same principal, porous membranes
allowing the passing of molecules. However, the size
cutoff for trypan blue uptake and LDH leakage is not
known, and this could account for the difference in
data. We propose that a combination of oxidative stress,
membrane disruption and possibly other factors contrib-
uted to the decrease of cell viability by MNP-PEI. In
contrast, for MNP-PEI-PEG, the loss of cell viability
over this time period could be attributed to cellular
events other than oxidative stress and cell membrane
damage and requires further study. As both SH-SY5Y
and RAW264.7 cells possess complex functions due to
their origin, other factors in both intra- and extracellular
environments could be involved in the cellular
responses. More studies to investigate these factors are
underway in our laboratory.
Conclusion
Our findings show that great caution should be exer-
cised when interpreting cell viability data from common
commercial assays on novel nanoparticulates. Our data
strongly suggested that nanotoxicity analysis requires a
different approach compared to conventional toxicity
studies used for cytotoxic drugs and other molecules
which are usually much less complex and smaller than
nanostructures. Our results also indicate that cell
A1 
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 * 
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 * 
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  *  *     * 
Figure 5 Lipid peroxidation of SH-SY5Y and RAW 246.7 cells. LPO of the cells in response to MNP-PEI and MNP-PEI-PEG at 1.56 (white bar),
3.125 (light grey bar), 6.25 (grey bar), 12.5 (dark grey bar) and 25 μgm L
-1 (black bar) over a period of 72 h. A1 LPO of SH-SY5Y cells in response
to MNP-PEI, A2 LPO of RAW 246.7 cells in response to MNP-PEI, B1 LPO of SH-SY5Y cells in response to MNP-PEI-PEG and B2 LPO of RAW 246.7
cells in response to MNP-PEI-PEG. LPO values were calculated and expressed as nanomoles of MDA per milligram of cellular protein. (n =3±
SE.). Asterisk denotes significant increase compared to control cells (p, 0.05).
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Page 10 of 12viability measurement should be complemented with
analysis of other cellular events when interpreting the
cytotoxicity and biocompatibility profile of
nanoparticles.
Endnotes
aROS, LPO and LDH assays were previously checked for
interferences and found to be unaffected by the nano-
particle presence. All statistical significance was assessed
using t test analysis via Microsoft
® Excel
® 2010 (Micro-
soft Corporation, Redmond, WA, USA) to a 95% confi-
dence interval.
Additional material
Additional file 1: Supplementary tables. Two tables showing the
physiochemical properties of MNP and polymer-coated MNP carried out
by ICP analysis and photon correlation spectroscopy and the cellular
uptake of MNP and polymer-coated MNP in SH-SY5Y and RAW 264.7
cells at 0, 1.56, 6.25, 25 μgm L
-1 over 24 h (n = 3).
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Figure 6 Cell membrane integrity analysis via LDH leakage from cells. Assay carried out in SH-SY5Y and RAW 264.7 cells incubated with
MNP-PEI and MNP-PEI-PEG at 0 (white bar), 1.56 (light grey bar), 3.125 (grey bar), 6.25 (dark grey bar), 12.5 (very dark grey bar) and 25 μgm L
-1
(black bar) over a period of 72 h (n = 3 ± SE). A1 SH-SY5 cells incubated with MNP-PEI, A2 RAW 264.7 cells incubated with MNP-PEI, B1 SH-SY5
cells incubated MNP-PEI-PEG and B2 RAW 264.7 cells incubated with MNP-PEI-PEG. Results were calculated and compared to the positive control,
whereby cells were lysed and 100% LDH release was assumed. Asterisk denotes significant increase compared with basal levels of LDH (p, 0.05).
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